Investor profile
Thomas Suter
Corporate VC, Venture capital & Investor at Mirae Asset Capital Life Science
Thomas Suter is an Investor at Mirae Asset Capital Life Science, whose known portfolio counts 4 companies.
Is Thomas Suter a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Investor at Mirae Asset Capital Life Science, whose known portfolio counts 4 companies
- Candid Therapeutics
- Precede Biosciences
- Accent Therapeutics
- Attovia Therapeutics
Investor Profile
Thomas Suter is listed against sector Healthcare, and focus areas Biotech, Drug Discovery, Genomics and Pharma in the database.
Stage-wise, the deals at Mirae Asset Capital Life Science cluster around Growth, Series A and Series B rounds.
What the affiliated firm has backed is the closest available signal on whether Thomas Suter is worth approaching.
Colleagues at Mirae Asset Capital Life Science
Frequently asked questions
Who is Thomas Suter?
Thomas Suter is a corporate venture investor and venture capital investor based in Boston, Massachusetts, United States, listed as Investor at Mirae Asset Capital Life Science. The known portfolio of that firm counts 4 companies. That portfolio belongs to the firm, not to Thomas Suter personally.
What does Thomas Suter invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Genomics and Pharma. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Thomas Suter invest at?
Mirae Asset Capital Life Science appears in Growth, Series A and Series B rounds across its known deals, and Thomas Suter is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Thomas Suter listed at?
Thomas Suter is listed as Investor at Mirae Asset Capital Life Science. 2 other people in the database share a firm with Thomas Suter.
How do I contact Thomas Suter?
A LinkedIn page is on file for Thomas Suter. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal